Identification of Nat-Erlotinib:
No description |
Search images on Google Product Monograph
Active Ingredients:
DIN: 02483912
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01E - (ATC, WHO)
- L01EB - (ATC, WHO)
- L01EB02 - ERLOTINIB (WHO)